Ladenburg Thalmann Financial Services’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$57K Sell
1,301
-170
-12% -$6.83K ﹤0.01% 3431
2019
Q3
$53K Sell
1,471
-2,250
-60% -$86.3K ﹤0.01% 3407
2019
Q2
$153K Hold
3,721
﹤0.01% 2657
2019
Q1
$167K Sell
3,721
-200
-5% -$8.38K ﹤0.01% 2529
2018
Q4
$137K Sell
3,921
-571
-13% -$21.7K ﹤0.01% 2525
2018
Q3
$204K Buy
4,492
+450
+11% +$20.1K ﹤0.01% 2296
2018
Q2
$167K Hold
4,042
﹤0.01% 2371
2018
Q1
$167K Hold
4,042
﹤0.01% 2371
2017
Q4
$164K Buy
4,042
+2
+0% +$80 ﹤0.01% 2350
2017
Q3
$168K Buy
4,040
+1,200
+42% +$48K ﹤0.01% 2232
2017
Q2
$113K Hold
2,840
﹤0.01% 2443
2017
Q1
$107K Hold
2,840
﹤0.01% 2353
2016
Q4
$93K Buy
2,840
+2,170
+324% +$71K ﹤0.01% 2373
2016
Q3
$22K Hold
670
﹤0.01% 3329
2016
Q2
$18K Hold
670
﹤0.01% 3402
2016
Q1
$17K Hold
670
﹤0.01% 3364
2015
Q4
$21K Buy
670
+2
+0.3% +$61 ﹤0.01% 3181
2015
Q3
$18K Hold
668
﹤0.01% 3166
2015
Q2
$23K Buy
668
+500
+298% +$16.4K ﹤0.01% 3134
2015
Q1
$5K Buy
+168
New +$4.92K ﹤0.01% 3957

Other funds holding BBP

Ladenburg Thalmann Financial Services's BBP Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Virtus Biotech ETF (BBP) stake by 12% in Q4 2019, selling an estimated $6.83K and leaving 1,301 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3431.

Ladenburg Thalmann Financial Services first reported a position in BBP in Q1 2015 and has held it in 20 quarters since. The position peaked at $204K in Q3 2018. 17 funds tracked by Wall St. Rank hold BBP as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,301 shares of Virtus Biotech ETF worth $57K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 170 Virtus Biotech ETF shares in Q4 2019, an estimated $6.83K.
  • Virtus Biotech ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3431 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Virtus Biotech ETF in Q1 2015 and has held it in 20 quarters since.
  • Ladenburg Thalmann Financial Services's Virtus Biotech ETF position peaked at $204K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.